Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomerica (BMRA) EPS (Basic) (2016 - 2026)

Biomerica's EPS (Basic) history spans 17 years, with the latest figure at -$0.44 for Q1 2026.

  • Quarterly results put EPS (Basic) at -$0.44 for Q1 2026, up 8.33% from a year ago — trailing twelve months through Feb 2026 was -$1.58 (up 57.75% YoY), and the annual figure for FY2025 was -$2.16, up 23.94%.
  • EPS (Basic) for Q1 2026 was -$0.44 at Biomerica, up from -$0.45 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.0 in Q3 2025 to a low of -$2.57 in Q2 2024.
  • The 5-year median for EPS (Basic) is -$0.12 (2022), against an average of -$0.37.
  • The sharpest move saw EPS (Basic) crashed 2470.0% in 2024, then soared 100.12% in 2025.
  • Year by year, EPS (Basic) stood at -$0.12 in 2022, then grew by 25.0% to -$0.09 in 2023, then surged by 33.33% to -$0.06 in 2024, then crashed by 650.0% to -$0.45 in 2025, then rose by 2.22% to -$0.44 in 2026.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at -$0.44, -$0.45, and $0.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.